The molecular basis for this phenomenon remains incompletely understood, but in fact the ultimate requirement of Menin for KMT2A‐complex integrity seems to be limited to a small number of target genes (including the transcription factor MEIS1) that are particularly essential for leukemia cells, thereby creating an impressive therapeutic index. This evidence concerns the gene KMT2A and leukemia.